Dimethylarginine Dimethylaminohydrolase 2 (DDAH2) ELISA Kits

DDAH2 belongs to the dimethylarginine dimethylaminohydrolase (DDAH) gene family. Additionally we are shipping DDAH2 Antibodies (80) and DDAH2 Proteins (7) and many more products for this protein.

list all ELISA KIts Gene Name GeneID UniProt
DDAH2 23564 O95865
DDAH2 51793 Q99LD8
DDAH2 294239 Q6MG60
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top DDAH2 ELISA Kits at antibodies-online.com

Showing 10 out of 30 products:

Catalog No. Reactivity Sensitivity Range Images Quantity Delivery Price Details
Human 0.116 ng/mL 0.31 ng/mL - 20 ng/mL 96 Tests 13 to 16 Days
$736.84
Details
Rat
  96 Tests 2 to 3 Days
$713.90
Details
Dog
  96 Tests 15 to 18 Days
$707.14
Details
Guinea Pig
  96 Tests 15 to 18 Days
$707.14
Details
Chicken
  96 Tests 15 to 18 Days
$707.14
Details
Monkey
  96 Tests 15 to 18 Days
$707.14
Details
Mouse
  96 Tests 15 to 18 Days
$707.14
Details
Rabbit
  96 Tests 15 to 18 Days
$707.14
Details
Sheep
  96 Tests 15 to 18 Days
$707.14
Details
Pig
  96 Tests 15 to 18 Days
$707.14
Details

More ELISA Kits for DDAH2 Interaction Partners

Human Dimethylarginine Dimethylaminohydrolase 2 (DDAH2) interaction partners

  1. The presence of the rs805305 SNP in the DDAH2 gene was determined using genomic DNA extraction from buffy coat and whole blood samples by LGC group (Hertfordshire, UK).

  2. genetic variations in the DDAH2 gene may influence the ADMA concentration and erythropoietin resistance in MHD patients

  3. The main finding from this study was that it demonstrated that the C-allele of rs3087894 in DDAH1 is a risk factor for hypertension in the Kazakh group but a protective factor in the Uygur group. In addition, we did not find any genotype of DDAH1 and DDAH2 associated with hypertension in the Han group.

  4. Exogenous human DDAH2 gene promotes differentiation of rabbit bone marrow-derived endothelial progenitor cells into mature endothelial cells.

  5. expression of DDAH2 is associated with invasiveness of lung adenocarcinoma via tumor angiogenesis

  6. Inhibiting the expression of DDAH1, but not DDAH2, resulted in a significant increase in the sensitivity of the EVT cell line SGHPL-4 to tumour necrosis factor related apoptosis inducing ligand (TRAIL) induced apoptosis

  7. increased ADMA levels in rheumatoid arthritis do not appear to relate to DDAH genetic polymorphisms

  8. The percentage of senescent endothelial progenitor cells increased while the expression of DDAH2 decreased concomitantly with an increase in the plasma levels of asymmetric dimethylarginine in patients with type 2 diabetes mellitus.

  9. DDAH-1 is a specific molecular target for portal pressure reduction, through actions on ADMA-mediated regulation of eNOS activity.

  10. Our results suggest that the rs805304 C allele of the DDAH gene was associated with decreased risk of myocardial infarction and decreased risk of obesity.

  11. Homocysteine disrupts EPCs function via inducing the hypermethylation of DDAH2 promoter, suggesting a key role of epigenetic mechanism in the progression of atherosclerosis

  12. -476 to -469 of the DDAH2 promoter was a NF-kB responsive element and is important for the transactivation of DDAH2.

  13. The rs9267551 functional variant of the DDAH2 gene is associated with chronic kidney disease with carriers of the C allele having a lower risk of renal dysfunction independently from several confounders

  14. Our approaches revealed signature candidates of differentially hypermethylated genes of DDAH2 and DUSP1 which can be further developed as potential biomarkers for OSCC as diagnostic, prognostic and therapeutic targets in the future.

  15. Enhancing pulmonary DDAH II activity attenuates LPS-mediated lung leak in acute lung injury.

  16. There is a significant difference in distribution of DDAH2 gene polymorphism among hemodialysis patients compared to healthy individuals.

  17. DDAH2-1151 A/C polymorphism is associated with Chronic renal impairment in type 2 diabetes.

  18. Glucose-stimulated insulin secretion is increased in Ddah2-transgenic pancreatic islets by 33%, compared to its levels in wild-type mice.

  19. Suppression of DDAH2 expression is a culprit for homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells.

  20. Found that SNP rs2272592 in DDAH2 is associated with type 2 diabetes but SNP rs805304 in DDAH2 is not. DDAH2 SNP rs2272592 AG+GG genotypes are associated with genetic susceptibility to type 2 diabetes in Korean population.

Mouse (Murine) Dimethylarginine Dimethylaminohydrolase 2 (DDAH2) interaction partners

  1. the overexpression of DDAH2 attenuates myocardial fibrosis and protects against Diabetic cardiomyopathy DCM through activation of the DDAH/ADMA/NOS/NO pathway

  2. We conclude that pp60(Src) can directly inhibit DDAH II and this is involved in the increased ADMA levels that enhance eNOS uncoupling during the development of acute lung injury (ALI).

  3. In mild CKD, dysregulation of the ADMA/DDAH pathway in adipose tissue triggers lipodystrophy-like phenotype changes, including ectopic fat depositions.

  4. The Sirt1/DDAH2/secretagogin pathway is a novel regulator of glucose-stimulated insulin secretion.

  5. DDAH2/ADMA pathway can be a novel therapeutic target for vasculopathy in the ADMA or angiotensin II-induced pathophysiological conditions

  6. Report tissue-specific downregulation of DDAH2 in hyperhomocysteinemia.

  7. Results show that asymmetric methylarginine increases pulmonary endothelial permeability, and that its effects on permeability, Rac1 activation and VASP phosphorylation are prevented by overexpression of active DDAHI and DDAHII.

  8. ADMA and nitrosative stress are related to increased expression of protein-arginine methyltransferase-2, an ADMA-synthesizing enzyme, and reduced expression of dimethylarginine dimethylaminohydrolase-2, an ADMA-degrading enzyme, in bronchial epithelia

DDAH2 Antigen Profile

Antigen Summary

This gene belongs to the dimethylarginine dimethylaminohydrolase (DDAH) gene family. The encoded enzyme plays a role in nitric oxide generation by regulating cellular concentrations of methylarginines, which in turn inhibit nitric oxide synthase activity.

Gene names and symbols associated with DDAH2

  • dimethylarginine dimethylaminohydrolase 2 (ddah2) antibody
  • dimethylarginine dimethylaminohydrolase 2 L homeolog (ddah2.L) antibody
  • dimethylarginine dimethylaminohydrolase 2 (DDAH2) antibody
  • dimethylarginine dimethylaminohydrolase 2 (Ddah2) antibody
  • 1110003M04Rik antibody
  • AU019324 antibody
  • AW413173 antibody
  • Ddah antibody
  • DDAH-2 antibody
  • DDAH2 antibody
  • DDAHII antibody
  • G6a antibody
  • MGC84290 antibody
  • MGC89103 antibody
  • NG30 antibody

Protein level used designations for DDAH2

NG,NG-dimethylarginine dimethylaminohydrolase 2 , dimethylarginine dimethylaminohydrolase 2 , DDAH-2 , N(G),N(G)-dimethylarginine dimethylaminohydrolase 2 , NG-dimethylarginine dimethylamino hydrolase homolog , S-phase protein , alternative name: NG30, G6a , dimethylargininase-2 , dimethylarginine dimethylaminohydrolase II , protein G6a , Clone 7u , DDAHII

GENE ID SPECIES
100194775 Salmo salar
447573 Xenopus laevis
448306 Xenopus (Silurana) tropicalis
716356 Macaca mulatta
745121 Pan troglodytes
23564 Homo sapiens
51793 Mus musculus
474846 Canis lupus familiaris
540386 Bos taurus
294239 Rattus norvegicus
100720724 Cavia porcellus
100352259 Oryctolagus cuniculus
101118391 Ovis aries
Selected quality suppliers for DDAH2 (DDAH2) ELISA Kits
Did you look for something else?